Guardant Health
Conquering Cancer With Data
Visit GuardantHealth.com
Visit GuardantHealth.com
Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.
WIRED | New Types of Tests That Can Change Healthcare
WIRED | New Types of Tests That Can Change Healthcare
Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health event in Boston.
Fast Company | Extending cancer prevention’s reach
Fast Company | Extending cancer prevention’s reach
A simple blood draw could help improve early detection
Milken Institute Power of Ideas Series | AmirAli Talasaz
Milken Institute Power of Ideas Series | AmirAli Talasaz
WIRED Health | Winning The War On Cancer
WIRED Health | Winning The War On Cancer
This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, and a day’s worth of insights and provocative conversations.
Washington Post | Some blood tests promise to detect cancer
Washington Post | Some blood tests promise to detect cancer
A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the blood.
Aspen Ideas 2025 | New Frontiers in Cancer Panel
Aspen Ideas 2025 | New Frontiers in Cancer Panel
The march against cancer continues, with remarkable progress in diagnostics and treatment. As our understanding of cancer grows, advances in blood-test screening, immunotherapy, CRISPR technology, artificial intelligence, and precision medicine bring us to a new frontier of hope. Yet both data and personal experiences remind us that much work lies ahead. Cancer rivals heart disease as a leading killer, disease rates are rising among young people, and broad access to cutting-edge medicine remains limited. Refining, scaling, and sharing innovative techniques and technology are key scientific goals.
NYT | Drug-Defying Breast Cancers Spotted Early in Blood Test Study
NYT | Drug-Defying Breast Cancers Spotted Early in Blood Test Study
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life
TIME100 Health: AmirAli Talasaz and Helmy Eltoukhy
TIME100 Health: AmirAli Talasaz and Helmy Eltoukhy
Find out why they're on the TIME100 Health list.
Breaking New Ground in the Fight Against Cancer Panel
Breaking New Ground in the Fight Against Cancer Panel
Cancer continues to be one of the leading causes of death worldwide. By 2040, the number of new cancer cases is expected to reach nearly 30 million. With rapid advances in science and technology, invasive methods for diagnosing and surveilling cancers are being supplanted by innovative, non-invasive methods like liquid biopsy. How might these technologies disrupt current practices? This panel of experts will offer a look into the innovations on the horizon and a prediction of how these innovations will affect the future of cancer care.
CRC Screening Insights Survey
CRC Screening Insights Survey
93% of primary care providers believe patients are less likely to avoid screening if presented with an FDA-approved blood test option March is Colorectal Cancer Awareness Month Shield is first blood test approved by FDA as a primary screening option for CRC Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of the second annual Closing the Gap: CRC Screening Insights survey, which showed that nine out of ten physicians surveyed a
View on mobile